Scilex Holding Company Banner Image

Scilex Holding Company

  • Ticker SCLX
    Exchange NASDAQ More
  • Industry Drug Manufacturers - Major More
  • Sector Healthcare More
Scilex Holding Company Logo Image
  • 51-200 Employees
  • Based in Palo Alto, California
Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Scilex is uncompromising in its focus to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceuticalMore products to maximize quality of life. Results from the Phase III Pivotal Trial C.L.E.A.R. Program for SEMDEXATM, its novel, non-opioid product for the treatment of lumbosacral radicular pain (sciatica), were announced in March 2022. Scilex submitted a request to the FDA for a type C meeting for purposes of pre-NDA discussion with the FDA.
5.0 / 5.0 (1)

Scilex Holding Company reports have an aggregate usefulness score of 5.0 based on 1 reviews.

Scilex Holding Company

Most Recent Annual Report

Scilex Holding Company
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Scilex Holding Company Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!